MacroGenics | MGNX - Assets

Stock Price
3.22
Daily Change
0.15 4.89%
Monthly
36.44%
Yearly
192.73%
Q2 Forecast
2.98

MacroGenics reported $256.85M in Assets for its fiscal quarter ending in December of 2025.





Assets Change Date
AbbVie USD 133.96B 62M Dec/2025
Amgen USD 90.59B 445M Dec/2025
AstraZeneca USD 114.07B 382M Dec/2025
Biogen USD 29.44B 232M Dec/2025
Bristol-Myers Squibb USD 96.89B 2.21B Sep/2025
Daiichi Sankyo JPY 3.82T 252.52B Dec/2025
Eli Lilly USD 112.48B 2.46B Dec/2025
Genmab DKK 12.87B 5.85B Dec/2025
Geron USD 570.54M 3.16M Dec/2025
Gilead Sciences USD 59.02B 490M Dec/2025
J&J USD 199.21B 6.39B Dec/2025
Karyopharm Therapeutics USD 108.42M 12.18M Dec/2025
MacroGenics USD 256.85M 13.92M Dec/2025
Merck USD 129.55B 12.02B Sep/2025
Pfizer USD 208.73B 2.64B Sep/2025
Puma Biotechnology USD 202.86M 7.95M Sep/2025
Regeneron Pharmaceuticals USD 40.56B 389.3M Dec/2025
Roche Holding CHF 100.7B 5.94B Dec/2025
Xencor USD 875.5M 6.68M Dec/2025